ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2590

Pesticide Use and Incident Rheumatoid Arthritis Among Spouses in the Agricultural Health Study: An Updated Analysis

Christine Parks1, Karen Costenbader2, Laura Beane Freeman3, Jonathan Hofmann3 and Dale Sandler4, 1National Institute of Environmental Health Sciences, Epidemiology Branch, Rese, 2Brigham and Women's Hospital/ Harvard Medical School, Boston, MA, 3National Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD, 4Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC

Meeting: ACR Convergence 2024

Keywords: Cohort Study, Environmental factors, Occupation, rheumatoid arthritis, Women's health

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: Abstracts: ARP Interprofessional I: Epidemiology & Methods

Session Type: Abstract Session

Session Time: 1:00PM-2:30PM

Background/Purpose:

Systemic autoimmune rheumatic diseases have been associated with farming exposures, but the role of pesticides has not been well studied. The Agricultural Health Study (AHS) cohort includes 32,345 spouses (99% female) of licensed pesticide applicators, who enrolled in 1993-1997 in North Carolina and Iowa, and completed up to 4 follow-up surveys through 2021. In a prior AHS study of rheumatoid arthritis (RA), including 123 incident cases (self-reported and medically confirmed) through 2010, RA was associated with use of any agricultural pesticides, the organochlorine insecticide dichlorodiphenyltrichloroethane (DDT), the herbicide glyphosate, and the fungicides maneb/mancozeb. Interpretation was limited by the small number of cases and lack of follow-up data on ~40% of enrolled spouses.  

Methods: This current study included 10 more years of active follow-up, an expanded case identification, and updated exposure data up to 2010. Self-reported cases were confirmed by use of disease modifying anti-rheumatic drugs and medical records, mortality with RA, and Medicare fee-for-service (FFS) claims data for RA among those ages 65 years and older in 1999-2016 (i.e., ≥2 RA claims >30 days apart, including ≥1 specialist claim(s)). Non-cases had a negative self-report of RA by questionnaire and/or no FFS RA claims. We examined associations of RA with use of 31 pesticides with ≥11 exposed cases. Using logistic regression in a complete case analysis, we calculated odds ratios (OR) and 95% confidence intervals (CI), adjusting for age, state, race/ethnicity, education, pack-years smoking, and body mass index.  

Results: We identified 480 incident cases (median diagnosis age 62 years, interquartile range 54-70) and 28,453 non-cases; most were non-Hispanic white (97% cases, 96% non-cases) and from Iowa (57% cases, 69% non-cases). Cases were older (median age 51 vs. 45 years non-cases) and reported more smoking pack-years at enrollment (Table 1). The most commonly reported pesticides were the insecticides, carbaryl (38% of cases vs. 36% non-cases) and malathion (25% vs. 21%), and the herbicides, glyphosate (44% vs. 41%) and 2,4-D (18% vs. 17%)(Table 2). In adjusted models, we confirmed RA associations with DDT (OR 1.91; 95%CI 1.31-2.77) and glyphosate (1.23;1.01-1.51), but not maneb/mancozeb (OR 1.57;0.89-2.77). New associations (ORs >1.8) were seen for several insecticides (lindane, coumaphos, terbufos, and carbofuran: ORs 1.89-2.50), herbicides (metolachlor, butylate, cyanazine, metribuzin, chlorimuron ethyl, and imazethapyr: ORs 1.87-2.66), and 2 fungicides (captan, and metalaxyl: ORs 1.87 and 2.22). After correcting for multiple testing (Bonferoni α=0.05/31=0.0016), RA associations with DDT, carbofuran, metribuzin, and metalaxyl remained statistically significant.  

Conclusion: We found positive associations of multiple insecticides, herbicides, and fungicides with RA, but not all pesticides examined. Strong and significant ORs for several specific pesticides suggest a possible role in the development of RA among AHS female spouses. Planned analyses will consider patterns of pesticide use and related exposures, and potential modifiers, such as age and early life farm residence.

Supporting image 1

Table 1. Characteristics of study sample: female spouses in the Agricultural Health Study

Supporting image 2

Table 2. Pesticides associated with rheumatoid arthritis in female spouses in the Agricultural Health Study


Disclosures: C. Parks: None; K. Costenbader: Amgen, 2, 5, AstraZeneca, 5, Bain HealthSciences, 2, Bristol-Myers Squibb(BMS), 2, Cabaletta Bio, 2, 5, Exagen, 5, Gilead, 5, Glaxo Smith Kline, 2, 5, Merck, 5; L. Beane Freeman: None; J. Hofmann: None; D. Sandler: None.

To cite this abstract in AMA style:

Parks C, Costenbader K, Beane Freeman L, Hofmann J, Sandler D. Pesticide Use and Incident Rheumatoid Arthritis Among Spouses in the Agricultural Health Study: An Updated Analysis [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/pesticide-use-and-incident-rheumatoid-arthritis-among-spouses-in-the-agricultural-health-study-an-updated-analysis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pesticide-use-and-incident-rheumatoid-arthritis-among-spouses-in-the-agricultural-health-study-an-updated-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology